Human Gene Module / Chromosome 9 / GABBR2

GABBR2gamma-aminobutyric acid type B receptor subunit 2

SFARI Gene Score
2S
Strong Candidate, Syndromic Criteria 2.1, Syndromic
Autism Reports / Total Reports
6 / 15
Rare Variants / Common Variants
17 / 0
Aliases
GABBR2, EIEE59,  GABABR2,  GPR51,  GPRC3B,  HG20,  HRIHFB2099
Associated Syndromes
-
Chromosome Band
9q22.33
Associated Disorders
ID, ASD
Relevance to Autism

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

Molecular Function

The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own.

SFARI Genomic Platforms
Reports related to GABBR2 (15 Reports)
# Type Title Author, Year Autism Report Associated Disorders
1 Support Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice Gassmann M , et al. (2004) No -
2 Support Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits Mombereau C , et al. (2005) No -
3 Support Expression of GABA(B) receptors is altered in brains of subjects with autism Fatemi SH , et al. (2008) Yes -
4 Support Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study Fatemi SH , et al. (2011) No -
5 Primary De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies EuroEPINOMICS-RES Consortium , et al. (2014) No ASD
6 Support Identification of novel genetic causes of Rett syndrome-like phenotypes Lopes F , et al. (2016) No ID, developmental regression, autistic features, s
7 Support GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy Yoo Y , et al. (2017) No ASD
8 Support High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies Hamdan FF , et al. (2017) No -
9 Support Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder Takata A , et al. (2018) Yes -
10 Support A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett-like phenotype Vuillaume ML , et al. (2018) No -
11 Support De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism Cappi C , et al. (2019) No -
12 Support - Alonso-Gonzalez A et al. (2021) Yes -
13 Support - Chen S et al. (2021) Yes DD, ID
14 Support - Zhou X et al. (2022) Yes -
15 Support - Noa Bielopolski et al. (2023) Yes -
Rare Variants   (17)
Status Allele Change Residue Change Variant Type Inheritance Pattern Parental Transmission Family Type PubMed ID Author, Year
c.473C>T p.Ala158Val missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.530C>T p.Pro177Leu missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.745C>T p.Arg249Trp missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.1699G>A p.Ala567Thr missense_variant De novo - - 34800434 Chen S et al. (2021)
c.1700C>T p.Ala567Val missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.1723A>T p.Thr575Ser missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.2012G>A p.Gly671Asp missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.1338C>T p.Ala446%3D synonymous_variant De novo - - 35982159 Zhou X et al. (2022)
c.1699G>A p.Ala567Thr missense_variant De novo - - 26740508 Lopes F , et al. (2016)
c.2077G>T p.Gly693Trp missense_variant De novo - - 29100083 Hamdan FF , et al. (2017)
c.1699G>A p.Ala567Thr missense_variant De novo - Simplex 28856709 Yoo Y , et al. (2017)
c.399C>T p.Gly133= synonymous_variant De novo - Simplex 31771860 Cappi C , et al. (2019)
c.635G>A p.Arg212Gln missense_variant De novo - - 38076211 Noa Bielopolski et al. (2023)
c.1699G>A p.Ala567Thr missense_variant De novo - Simplex 29346770 Takata A , et al. (2018)
c.1699G>A p.Ala567Thr missense_variant De novo - Simplex 33431980 Alonso-Gonzalez A et al. (2021)
c.2084G>T p.Ser695Ile missense_variant De novo - Simplex 25262651 EuroEPINOMICS-RES Consortium , et al. (2014)
c.2114T>A p.Ile705Asn missense_variant De novo - Simplex 25262651 EuroEPINOMICS-RES Consortium , et al. (2014)
Common Variants  

No common variants reported.

SFARI Gene score
2S

Strong Candidate, Syndromic

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

Score Delta: Score remained at 2S

2

Strong Candidate

See all Category 2 Genes

We considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.

The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."

4/1/2022
3S
icon
2S

Decreased from 3S to 2S

Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

1/1/2021
3S
icon
3S

Decreased from 3S to 3S

Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

7/1/2020
3S
icon
3S

Decreased from 3S to 3S

Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

1/1/2020
3S
icon
3S

Decreased from 3S to 3S

Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

10/1/2019
4S
icon
3S

Decreased from 4S to 3S

New Scoring Scheme
Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

Reports Added
[New Scoring Scheme]
7/1/2018
icon
4S

Increased from to 4S

Description

De novo mutations in the GABBR2 gene are associated with a form of early-infantile epileptic encephalopathy (EIEE59; OMIM 617904) (EuroEPINOMICS-RES Consortium 2014; Hamdan et al., 2017), as well as with a Rett syndrome-like disorder called neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS; OMIM 617903) (Lopes et al., 2016; Yoo et al., 2017; Vuillaume et al., 2018). One individual with GABBR2-mediated epileptic encephalopathy that was reported in EuroEPINOMICS-RES Consortium 2014 also presented with autism spectrum disorder, whereas individuals with GABBR2-mediated NDPLHS have been reported with autism spectrum disorder, autistic features, and/or stereotypic hand movements. The same recurrent de novo missense variant in GABBR2 that was observed in individuals from Lopes et al., 2016 and Yoo et al., 2017 (p.Ala567Thr) was also identified in a Japanese ASD proband in Takata et al., 2018.

Krishnan Probability Score

Score 0.64741431954756

Ranking 41/25841 scored genes


[Show Scoring Methodology]
Krishnan and colleagues generated probability scores genome-wide by using a machine learning approach on a human brain-specific gene network. The method was first presented in Nat Neurosci 19, 1454-1462 (2016), and scores for more than 25,000 RefSeq genes can be accessed in column G of supplementary table 3 (see: http://www.nature.com/neuro/journal/v19/n11/extref/nn.4353-S5.xlsx). A searchable browser, with the ability to view networks of associated ASD risk genes, can be found at asd.princeton.edu.
ExAC Score

Score 0.99979026252187

Ranking 781/18225 scored genes


[Show Scoring Methodology]
The Exome Aggregation Consortium (ExAC) is a summary database of 60,706 exomes that has been widely used to estimate 'constraint' on mutation for individual genes. It was introduced by Lek et al. Nature 536, 285-291 (2016), and the ExAC browser can be found at exac.broadinstitute.org. The pLI score was developed as measure of intolerance to loss-of- function mutation. A pLI > 0.9 is generally viewed as highly constrained, and thus any loss-of- function mutations in autism in such a gene would be more likely to confer risk. For a full list of pLI scores see: ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3.1/functional_gene_constraint/fordist_cle aned_exac_nonTCGA_z_pli_rec_null_data.txt
Sanders TADA Score

Score 0.94545108356248

Ranking 16475/18665 scored genes


[Show Scoring Methodology]
The TADA score ('Transmission and De novo Association') was introduced by He et al. PLoS Genet 9(8):e1003671 (2013), and is a statistic that integrates evidence from both de novo and transmitted mutations. It forms the basis for the claim of 65 individual genes being strongly associated with autism risk at a false discovery rate of 0.1 (Sanders et al. Neuron 87, 1215-1233 (2015)). The calculated TADA score for 18,665 RefSeq genes can be found in column P of Supplementary Table 6 in the Sanders et al. paper (the column headed 'tadaFdrAscSscExomeSscAgpSmallDel'), which represents a combined analysis of exome data and small de novo deletions (see www.cell.com/cms/attachment/2038545319/2052606711/mmc7.xlsx).
Submit New Gene

Report an Error